These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15333076)

  • 1. Jumping in before the water is hot: the need to support randomized controlled clinical trials.
    Epstein AE
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):867-9. PubMed ID: 15333076
    [No Abstract]   [Full Text] [Related]  

  • 2. Biventricular implantable cardioverter defibrillators improve survival compared with biventricular pacing alone in patients with severe left ventricular dysfunction.
    Ermis C; Lurie KG; Zhu AX; Collins J; Vanheel L; Sakaguchi S; Lu F; Pham S; Benditt DG
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):862-6. PubMed ID: 15333075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRT-D therapy in heart failure: how much do NYHA class IV patients benefit?
    Lehmann MH; Aaronson KD
    J Cardiovasc Electrophysiol; 2006 May; 17(5):491-4. PubMed ID: 16684020
    [No Abstract]   [Full Text] [Related]  

  • 4. The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation.
    Sweeney MO; Ellenbogen KA; Miller EH; Sherfesee L; Sheldon T; Whellan D
    J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1295-8. PubMed ID: 17081208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between women and men with ICDs: myth or reality?
    Pelargonio G; Bisceglia C
    J Cardiovasc Electrophysiol; 2009 Sep; 20(9):979-81. PubMed ID: 19563354
    [No Abstract]   [Full Text] [Related]  

  • 6. Jumping in before the water is hot: the need to support randomized controlled clinical trials.
    Bai R
    J Cardiovasc Electrophysiol; 2005 Jun; 16(6):678; author reply 678-9. PubMed ID: 15946376
    [No Abstract]   [Full Text] [Related]  

  • 7. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
    Zareba W; Piotrowicz K; McNitt S; Moss AJ;
    Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early mortality in implantable cardioverter defibrillator patients: from randomized controlled trials to real life.
    Köbe J; Eckardt L
    Europace; 2009 Jun; 11(6):694-6. PubMed ID: 19470594
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cardiac resynchronization therapy with or without defibrillation backup: everything has been written?].
    Botto GL; Luzi M; Russo G; Mariconti B
    G Ital Cardiol (Rome); 2010 Apr; 11(4):306-9. PubMed ID: 20677576
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cardiac resynchronization therapy].
    Karczmarewicz S
    Kardiol Pol; 2003 Jul; 59(7):83-5. PubMed ID: 14560359
    [No Abstract]   [Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillators in patients with Chagas heart disease: misperceptions, many questions and the urgent need for a randomized clinical trial.
    Rassi A
    J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1241-3. PubMed ID: 17971129
    [No Abstract]   [Full Text] [Related]  

  • 12. Getting the most out of life.
    Schwartzman D
    J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1167-8. PubMed ID: 18631267
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiac resynchronization therapy or atrio-biventricular pacing-what should it be called?
    Cleland JG; Nasir M; Tageldien A
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4(2):90-101. PubMed ID: 17245403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of left ventricular lead position on clinical outcomes in the COMPANION study: does placement really matter?
    Freedberg NA
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):769-72. PubMed ID: 19460075
    [No Abstract]   [Full Text] [Related]  

  • 17. Device therapy in the management of congestive heart failure.
    Turer AT; Rao SV
    Cardiol Rev; 2005; 13(3):130-8. PubMed ID: 15831146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular assist devices as destination therapy: a new look at survival.
    Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillators.
    Bunch TJ; Hohnloser SH; Gersh BJ
    Circulation; 2007 May; 115(18):2451-7. PubMed ID: 17485594
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction of right ventricular pacing in patients with dual-chamber ICDs.
    Olshansky B; Day J; McGuire M; Hahn S; Brown S; Lerew DR
    Pacing Clin Electrophysiol; 2006 Mar; 29(3):237-43. PubMed ID: 16606390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.